Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16 is a candidate tumour-suppressor protein that maps to a genomic locus strongly associated with familial melanoma and other tumour types. Screening of primary tumours and linkage analysis of familial melanoma pedigrees have identified many potential mutations in p16, but the functional significance of these sequence variants has remained unclear. We report here that p16 can act as a potent and specific inhibitor of progression through the G1 phase of the cell cycle, and we demonstrate that several tumour-derived alleles of p16 encode functionally compromised proteins. The ability of p16 to arrest cell-cycle progression generally correlates with inhibition of cyclin D1/Cdk4 kinase activity in vitro, with two exceptions among the alleles tested. In vivo, the presence of functional retinoblastoma protein appears to be necessary but may not be sufficient to confer full sensitivity to p16-mediated growth arrest. Our results provide support for the notion that p16 is an important cell-cycle regulator whose inactivation contributes to the outgrowth of human tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, cells lacking functional RB were resistant to p16INK4a-mediated cell cycle arrest, implying that the ability of CDK4 (and later, CDK6) to drive G1 phase progression required RB (33-35) and predicting that chemical CDK4/6 inhibitors would show efficacy only if RB were functionally intact.”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [35]
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Research works printed but not linked: 2
- Mori, T. et al. Canc. Res. 54, 3396–3397 (1994).
- Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W. & Kaye, F. J. Oncogene 9, 3375–3378 (1994).
Cited by
Items 301–400 of 513
Genetic Determinants of Cutaneous Melanoma Predisposition
Udayakumar, D., Mahato, B., Gabree, M., & Tsao, H. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.06.002 · Cited by 45
Mehramiz, M., Ghasemi, F., Esmaily, H., Tayefi, M., Hassanian, S. M., Sadeghzade, M., Sadabadi, F., Moohebati, M., Azarpazhooh, M. R., Parizadeh, S. M. R., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.018 · Cited by 34
Berman, H. K., Gauthier, M. L., & Tlsty, T. D. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0073 · Cited by 36
Immunocytochemical Detection of p16INK4a Protein in Scraped Cervical Cells
Pientong, C., Ekalaksananan, T., Swadpanich, U., Kongyingyoes, B., Kritpetcharat, O., Yuenyao, P., & Ruckait, N. (2003) · Acta Cytologica · doi:10.1159/000326578 · Cited by 35
Cell Cycle Control in Fission Yeast and Mammals: Identification of New Regulatory Mechanisms
Okayama, H., Nagata, A., Jinno, S., Murakami, H., Tanaka, K., & Nakashima, N. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60859-3 · Cited by 34
E2Fs and the Retinoblastoma Protein Family
Sardet, C., Cam, L. L., Fabbrizio, E., & Vidal, M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_1 · Cited by 37
Psoriatic epidermis is associated with upregulation of CDK 2 and inhibition of CDK 4 activity
Henri, P., Prével, C., Pellerano, M., Lacotte, J., Stoebner, P., Morris, M. C., & Meunier, L. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18178 · Cited by 32
Familial Head and Neck Cancer: Molecular Analysis of a New Clinical Entity
Yu, K. K., Zanation, A. M., Moss, J. R., & Yarbrough, W. G. (2002) · The Laryngoscope · doi:10.1097/00005537-200209000-00010 · Cited by 36
The RB Protein Family in Retinal Development and Retinoblastoma: New Insights from New Mouse Models
Bremner, R., Chen, D., Pacal, M., Livne‐Bar, I., & Agochiya, M. (2004) · Developmental Neuroscience · doi:10.1159/000082284 · Cited by 37
Tumor Suppressor Genes and Human Cancer
Brown, M. A. (1997) · Advances in genetics · doi:10.1016/s0065-2660(08)60307-7 · Cited by 39
Jones, C. J., Shaw, J. J., Wyllie, F. S., Gaillard, N., Schlumberger, M. J., & Wynford‐Thomas, D. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03697-0 · Cited by 31
Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression
Zhang, L., Peng, L., Hsu, T., Aguilar, H. R., Frantz, D. E., Schneider, J. W., Bachoo, R. M., & Hsieh, J. (2011) · Differentiation · doi:10.1016/j.diff.2011.02.005 · Cited by 32
Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
Gadd, M. A., Pisc, C., Branda, J., Ionescu-Tiba, V., Nikolić, Ž., Yang, C., Wang, T. C., Shackleford, G. M., Cardiff, R. D., & Schmidt, E. V. (2001) · PubMed · Cited by 34
Noh, S. J., Li, Y., Xiong, Y., & Guan, K. (1999) · PubMed · Cited by 30
Relationship between Ras pathways and cell cycle control
Ewen, M. E. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_1 · Cited by 37
Silva, G. P. D. L., & Aboussekhra, A. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22299 · Cited by 31
Familial Melanoma–Associated Mutations in p16 Uncouple its Tumor-Suppressor Functions
Jenkins, N., Jung, J., Liu, T., Wilde, M., Holmen, S. L., & Grossman, D. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.401 · Cited by 33
Obeyesekere, M. N., Knudsen, E. S., Wang, J. Y. J., & Zimmerman, S. O. (1997) · Cell Proliferation · doi:10.1111/j.1365-2184.1997.tb00933.x · Cited by 32
Heidenreich, A., Gaddipati, J. P., Moul, J. W., & Srivastava, S. K. (1998) · The Journal of Urology · doi:10.1097/00005392-199805000-00101 · Cited by 29
Cancer Genetics in the New Era of Molecular Biology
Lynch, H., Fusaro, R., & Lynch, J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48588.x · Cited by 30
Prognostic Value of Overexpressed p16INK4a in Vulvar Cancer: A Meta-Analysis
Cao, H., Wang, S., Zhang, Z., & Lou, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152459 · Cited by 32
Al‐Khalaf, H. H., & Aboussekhra, A. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22564 · Cited by 32
Tumor Suppressor Genes in Prostate Cancer
Bookstein, R. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-009-4_5 · Cited by 33
Mammalian Interphase Cdks: Dispensable Master Regulators of the Cell Cycle
Enders, G. H. (2012) · Genes & Cancer · doi:10.1177/1947601913479799 · Cited by 30
Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids
Viola, J. R., Rafael, D. F. D. S., Wagner, E., Besch, R., & Ogris, M. (2013) · Journal of Drug Delivery · doi:10.1155/2013/897348 · Cited by 29
Serizawa, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5427 · Cited by 32
Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia
Kumagai, T., Tefferi, A., Jones, L. C., & Koeffler, H. P. (2005) · Leukemia Research · doi:10.1016/j.leukres.2004.11.002 · Cited by 27
Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells
Terada, Y., Inoshita, S., Nakashima, O., Tamamori, M., Ito, H., Kuwahara, M., Sasaki, S., & Marumo, F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00568.x · Cited by 27
Germline and Somatic Mutations of the INK4a-ARF Gene in a Xeroderma Pigmentosum Group C Patient
Soufir, N., Ribojad, M., Magnaldo, T., Thibaudeau, O., Delestaing, G., Daya–Grosjean, L., Rivet, J., Sarasin, A. R., & Basset‐Séguin, N. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19603.x · Cited by 28
Regulation of Cell Cycle Entry and Exit: A Single Cell Perspective
Coller, H. A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190014 · Cited by 34
Francis, S. M., Bergsied, J., Isaac, C. E., Coschi, C. H., Martens, A. L., Hojilla, C. V., Chakrabarti, S., DiMattia, G. E., Khoka, R., Wang, J. Y. J., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00473-09 · Cited by 31
Li, Z., Roch, K. G. L., Geyer, J. A., Woodard, C. L., Prigge, S. T., Koh, J., Doerig, C., & Waters, N. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5920 · Cited by 26
Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue
Goldsworthy, S. M., Stockton, P. S., Trempus, C. S., Foley, J. F., & Maronpot, R. R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199906)25:2<86::aid-mc2>3.0.co;2-4 · Cited by 345
Gurushankar, K., Rimac, H., Potemkin, V., & Grishina, M. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.129925 · Cited by 27
Blais, A., Labrie, Y., Pouliot, F., Lachance, Y., & Labrie, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8497 · Cited by 29
G1/S regulatory mechanisms from yeast to man
Reed, S. I. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_2 · Cited by 27
Ríos, R., Lupiañez, C. B., Campa, D., Hielscher, T., Weinhold, N., Martínez‐López, J., Jerez, A., Landi, S., Jamroziak, K., Dumontet, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10665 · Cited by 25
Chao, H. H., Buchmann, A. M., & DeCaprio, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7624-7633.2000 · Cited by 28
NMR structural characterization of the CDK inhibitor p19INK4d
Kalus, W., Baumgartner, R., Renner, C., Noegel, A. A., Chan, F. K. M., Winoto, A., & Holak, T. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01465-2 · Cited by 30
Nishiwaki, E., Turner, S. L., Harju-Baker, S., Miyazaki, S., Kashiwagi, M., Koh, J., & Serizawa, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7726-7734.2000 · Cited by 35
Chen, L., Stuart, L. M., Ohsumi, T. K., Burgess, S. M., Varshney, G. K., Dastur, A., Borowsky, M. L., Benes, C. H., Lacy‐Hulbert, A., & Schmidt, E. V. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-93 · Cited by 25
p16ink4aGene and Hematological Malignancies
Quesnel, B., Preudhomme, C., & Fenaux, P. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609051724 · Cited by 25
Decreased number of p16-positive senescent cells in human endometrium as a marker of miscarriage
Parvanov, D. A., Ganeva, R., Vidolova, N., & Stamenov, G. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02182-5 · Cited by 29
Agarwal, P., Kabir, F. M. L., DeInnocentes, P., & Curtis, R. (2012) · InTech eBooks · doi:10.5772/27882 · Cited by 32
Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung
Xue, Q., Sano, T., Kashiwabara, K., Saitō, M., Oyama, T., & Nakajima, T. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01321.x · Cited by 27
Lee, J., Park, C., Chun, K., & Hong, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.3360 · Cited by 23
Interruption of p16 gene expression in adult T‐cell leukaemia/lymphoma: clinical correlation
Takasaki, Y., Yamada, Y., Sugahara, K., Hayashi, T., Dateki, N., Harasawa, H., Kawabata, S., Soda, H., Ikeda, S., Tomonaga, M., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04377.x · Cited by 23
Expression of the cyclin‐dependent kinase inhibitor p16 during the ongoing cell cycle
Soucek, T., Pusch, O., Hengstschläger-Ottnad, E., Wawra, E., BERNASCHEK, G., & Hengstschläger, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01033-b · Cited by 23
The ARF‐p16 Gene Locus in Carcinogenesis and Therapy of Head and Neck Squamous Cell Carcinoma
Yarbrough, W. G. (2002) · The Laryngoscope · doi:10.1097/00005537-200212000-00002 · Cited by 23
The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy
Gensini, F., Sestini, R., Piazzini, M., Vignoli, M., Chiarugi, A., Brandani, P., Ghiorzo, P., Salvini, C., Borgognoni, L., Palli, D., et al. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f1d328 · Cited by 22
Wang, B., Li, Y.-Y., Han, J., Zhou, L.-Y., Lv, Y., Zhang, H., & Zhao, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15919 · Cited by 20
p16 Controls p53 Protein Expression Through miR-dependent Destabilization of MDM2
Al‐Khalaf, H. H., & Aboussekhra, A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0017 · Cited by 23
Precision medicine in Ewing sarcoma: a translational point of view
Gargallo, P., Juan, A. D., Yáñez, Y., Dolz, S., Segura, V., Castel, V., & Cañete, A. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02298-7 · Cited by 22
Nakanishi, M., Kaneko, Y. S., Matsushime, H., & Ikeda, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1296 · Cited by 24
Nagasawa, M., Gelfand, E. W., & Lucas, J. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204396 · Cited by 26
Liu, H., Urabe, K., Moroi, Y., Yasumoto, S., Kokuba, H., Imafuku, S., Koga, T., Masuda, T., Aburatani, H., Furue, M., et al. (2006) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2006.00438.x · Cited by 19
Obesity and p16 INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity
Al‐Khalaf, H. H., Amir, M., Almohanna, F., Tulbah, A. M., Alsayed, A., & Aboussekhra, A. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00101-17 · Cited by 19
Cyclin-Dependent Kinase Inhibitor 2b Mediates Excitotoxicity-Induced Death of Retinal Ganglion Cells
Tawarayama, H., Feng, Q., Murayama, N., Suzuki, N., & Nakazawa, T. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27396 · Cited by 19
Wiedemeyer, K., Guadagno, A., Davey, J., & Brenn, T. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001051 · Cited by 19
Jiang, H. N., Karnezis, A. N., Tao, M., Guida, P. M., & Zhu, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203722 · Cited by 21
Parreño, M., Garriga, J., Limón, A., Albrecht, J. H., & Graña, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204644 · Cited by 20
Sano, T., Hikino, T., Xue, Q., Saito, T., Kashiwabara, K., Oyama, T., & Nakajima, T. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01109.x · Cited by 20
Orr, M. S., Reinhold, W. C., Yu, L., Schreiber‐Agus, N., & O'Connor, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3803 · Cited by 19
Hong, S., Choi, J., Ryu, K., Ro, J. Y., & Yu, E. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-33-photpg · Cited by 19
Ríos, R., Lupiañez, C. B., Campa, D., Martino, A., Martínez‐López, J., Martínez‐Bueno, M., Várkonyi, J., García‐Sánz, R., Jamroziak, K., Dumontet, C., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0029 · Cited by 20
An immunohistochemical study of p16INK4a expression in multistep thyroid tumourigenesis
Ball, E., BOND, J. A., Franc, B., DeMicco, C., & Wynford‐Thomas, D. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.025 · Cited by 18
Lycan, D. E., Stafford, K. A., Bollinger, W., & Breeden, L. L. (1996) · Gene · doi:10.1016/0378-1119(96)00023-6 · Cited by 20
Molecular Biology of Malignant Mesothelioma: A Review
Pisick, E. P., & Salgia, R. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.09.012 · Cited by 19
Regulation of the Cell Cycle by the Rb Tumor Suppressor Family
Ewen, M. E. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69686-5_7 · Cited by 22
Hengstschläger, M., Pusch, O., Hengstschläger-Ottnad, E., Ambros, P. F., BERNASCHEK, G., & Wawra, E. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.41 · Cited by 18
Zouheir, Y., Fechtali, T., & Gnaoui, N. E. (2016) · Journal of Cancer Prevention · doi:10.15430/jcp.2016.21.2.121 · Cited by 17
Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence
Brookes, S., Gagrica, S., Sanij, E., Rowe, J., Gregory, F. J., Hara, E., & Peters, G. G. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1010866 · Cited by 21
A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma
Zhao, X., Song, T., Zhou-kang, H., Tang, L., & Zhu, Y. (2009) · Medical Oncology · doi:10.1007/s12032-009-9320-y · Cited by 17
Higashi, H., Suzuki‐Takahashi, I., Yoshida, E., Nishimura, S., & Kitagawa, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6181 · Cited by 18
Hirai, H., Adachi, T., & Tsubata, T. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401357 · Cited by 17
Suzuki, H. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000206 · Cited by 16
Fan, M., Pfeffer, S. R., Lynch, H. T., Cassidy, P. B., Leachman, S. A., Pfeffer, L. M., & Kopelovich, L. (2013) · Oncotarget · doi:10.18632/oncotarget.786 · Cited by 18
Cancer genetics: Two tracks but one race?
Sidransky, D. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00532-8 · Cited by 16
Grimison, B., Langan, T. A., & Sclafani, R. A. (2000) · PubMed · Cited by 18
Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies
Zob, D., Augustin, I. G., Caba, L., Pânzaru, M.-C., Popa, S., Popa, A. D., Florea, L., & Gorduza, E. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010716 · Cited by 16
Induction of p16/INK4a Gene Expression and Cellular Senescence by Toyocamycin.
Kurihara, Y., Egawa, K., Kunimoto, S., TAKEUCHI, T., & Nose, K. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1272 · Cited by 16
Al‐Khalaf, H. H., Nallar, S. C., Kalvakolanu, D. V., & Aboussekhra, A. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22627 · Cited by 17
Mori, A., Higashi, H., Hoshikawa, Y., Imamura, M., Asaka, M., & Hatakeyama, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203044 · Cited by 17
N-terminal acetylation can stabilize proteins independent of their ubiquitination
van de Kooij, B., de Vries, E., Rooswinkel, R. W., Janssen, G. M. C., Kok, F. K., van Veelen, P. A., & Borst, J. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-32380-3 · Cited by 16
P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
Auepemkiate, S., Thongsuksai, P., & Boonyaphiphat, P. (2006) · PubMed · Cited by 14
Mining the GEMS – a novel platform technology targeting post-transcriptional control mechanisms
Bhattacharyya, A., Trotta, C. R., & Peltz, S. W. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.05.009 · Cited by 15
Fluorescence-activated cell sorting of transfected cells
Adams, P. D., Lopez, P., Sellers, W. R., & Kaelin, W. G. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)83007-8 · Cited by 13
Retroviral transfer of the p16INK4a cDNA inhibits C6 glioma formation in Wistar rats
Strauss, B. E., Fontes, R. B. V., Lotfi, C. F. P., Skorupa, A. L., Bartol, I., Cipolla‐Neto, J., & Costanzi-Strauss, E. (2002) · Cancer Cell International · doi:10.1186/1475-2867-2-2 · Cited by 14
Alevizopoulos, K., Sanchez, B., & Amati, B. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203534 · Cited by 17
Fujiwara, H., Arima, N., Hashimoto-Tamaoki, T., Matsushita, K., Ohtsubo, H., Arimura, K., Hidaka, S., & Tei, C. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00035-1 · Cited by 14
Ying, C. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.1 · Cited by 13
Inactivation of Tumor Suppressor Proteins in Lung Cancer
Weintraub, S. J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.2.8703470 · Cited by 14
Marella, S. (2013) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-0842542 · Cited by 14
Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse, A., Homcha-em, P., Karalak, A., & Srivatanakul, P. (2008) · PubMed · Cited by 12
Ookawa, K., Tsuchida, S., Kohno, T., & Yokota, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02583-2 · Cited by 13
Inactivation of the p15 INK4B and p16 INK4 Genes in Hematologic Malignancies
Heyman, M. M., & Einhorn, S. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609054826 · Cited by 17
P16 INK4A overexpression predicts lymph node metastasis in cervical carcinomas
Huang, L., & Lee, C.-C. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200362 · Cited by 11
Lee, H. J., Jang, S. J., Chun, S., Park, S.-I., Kim, D. K., & Choi, J. (2011) · Experimental Lung Research · doi:10.3109/01902148.2011.577267 · Cited by 11
Vanneste, R., Smith, E., & Graham, G. E. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35884 · Cited by 11
Jones, C. (2000) · Breast Cancer Research · doi:10.1186/bcr-2000-66675 · Cited by 11
Metadata
- Authors
- Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E.
- Affiliations
- Massachusetts General Hospital (US)
- ORCID
- Koh, James
- Venue
- Nature
- Published
- 1995-06
- Volume
- 375
- Issue
- 6531
- Pages
- 506-510
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2035882662
- Cited by
- 516
- References
- 26
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 11 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 8
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p16, tumour suppressor, cyclin-dependent kinase inhibitors, G1 cell cycle arrest, retinoblastoma protein, familial melanoma, tumor progression, cell cycle regulation
- MeSH terms
- Alleles, Animals, Carrier Proteins, Cell Line, Humans, Mutation, Recombinant Proteins, Transfection, Tumor Cells, Cultured, Genes, Tumor Suppressor, G1 Phase, 3T3 Cells, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.